Updates for c.958T>G:
2025-11-07 Class updated from VUS to likely benign (based on high frequency in the general population and patients data)




Variant NM_000492.4:c.958T>G


Variant details:
Name NM_000492.4:c.958T>G
Protein name NP_000483.3:p.(Leu320Val)
Genomic name (hg19)     chr7:g.117180242T>G    UCSC    
Genomic name (hg38) chr7:g.117540188T>G    UCSC
#Exon/intron exon 8
Legacy Name L320V
Class likely benign
WT sequence CTTCTCAGGGTTCTTTGTGGTGTTT T TATCTGTGCTTCCCTATGCACTAAT
Mutant sequence CTTCTCAGGGTTCTTTGTGGTGTTT G TATCTGTGCTTCCCTATGCACTAAT

Other databases:
dbSNP
rs144476686



Pathogenicity predictors:



Response to modulators:


Modulator FDA approval EMA approval in vitro / ex vivo data clinical data
IVA yesnoyesno
TEZ-IVA yesnoyesno
ELX-TEZ-IVA yesnoyesno
VNZ-TEZ-DIVA yesnoyesno

clinical and functional data presented above are provided by Vertex


No patient found in CFTR-NGS catalogue


4 patients carrying this variant are reported in CFTR-France:

TOTAL NUMBER OF PATIENTS 4
Asymptomatic compound heterozygote 2
CFTR-RD2
  • CBAVD  1
  • Pancreatitis  1




Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing

Detailed genotypes:
Phenotype Patient ID Variant status Additional variants
Asymptomatic compound heterozygote 4691heterozygoteCF-causing - Trans
Asymptomatic compound heterozygote 4840heterozygote
Pancreatitis 1981heterozygoteCF-causing- Undef
CBAVD 2609heterozygoteCFTR-RD-causing- Undef


Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing



            CFTR variants are clustered into five groups (click here for more details about the classification of variants):
  • CF-causing: when in trans with another CF-causing mutation, will result in CF.
  • CFTR-RD causing: when in trans with a CF-causing mutation, will result in CFTR-related disorders (CFTR-RD) such as chronic pancreatitis, bronchiectasis, CRS-NP (chronic rhinosinusitis with or without nasal polyposis) or CBAVD (congenital absence of vas deferens), according to Bombieri C et al., 2011.
  • Varying clinical consequence: when in trans with another CF-causing mutation, can either result in CF or in a CFTR-RD.
  • Non disease-causing: when in trans with a CF-causing mutation, will not cause CF, nor CFTR-RD.
  • VUS (Variant of unknown clinical significance): unclassified because of insufficient data.



Go to CFTRare